Finance

Lists
SYNACT:STO
SynAct Pharma AB
SEK 17.64
-0.23%
(-0.040) 1D
Sep 29, 4:47:08 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for SYNACT...
Open
SEK 17.70
High
SEK 17.84
Low
SEK 17.38
Mkt. cap
991.61M
Avg. vol.
194.93K
Volume
42.25K
52-wk high
SEK 25.30
52-wk low
SEK 7.05
EPS
-SEK 1.97
Shares outstanding
56.21M
No. of employees
8
Open
SEK 17.70
High
SEK 17.84
Low
SEK 17.38
Mkt. cap
991.61M
Avg. vol.
194.93K
Volume
42.25K
52-wk high
SEK 25.30
52-wk low
SEK 7.05
EPS
-SEK 1.97
Shares outstanding
56.21M
No. of employees
8
About SynAct Pharma AB
CEOJeppe Øvlesen
Employees8
FoundedMar 14, 2012
Headquarters-
SectorBiotechnology
Websitesynactpharma.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
28.12M
12.32M
22.87M
15.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.77M
10.45M
7.71M
9.16M
Operating expense
35.38M
22.47M
30.56M
24.56M
Total operating expenses
35.38M
22.47M
30.56M
24.56M
Operating income
-35.38M
-22.47M
-30.56M
-24.56M
Other non operating income
-
-
1.00K
-1.00K
EBT including unusual items
-35.71M
-22.90M
-30.54M
-24.91M
EBT excluding unusual items
-35.71M
-22.90M
-30.54M
-24.91M
Income tax expense
-16.00K
27.00K
-5.06M
-2.88M
Effective tax rate
0.04%
-0.12%
16.56%
11.55%
Other operating expenses
-511.00K
-298.00K
-23.00K
-68.00K
Net income
-35.69M
-22.93M
-25.49M
-22.03M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
2.13M
13.00K
-
Interest expense
-330.00K
-
-
-353.00K
Net interest expenses
-330.00K
2.13M
13.00K
-353.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-22.47M
-30.55M
-24.55M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps